Aarhus University Hospital
Aarhus, 8000, Denmark
NCT Number: NCT01344395
The primary aim of this study is to evaluate if multiple postoperative administrations with a solution of ropivacaine, ketorolac and epinephrine into the operating field through a catheter would affect morphine consumption. Secondary end-points are pain intensity, side effects and length of stay.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 4
Aarhus, 8000, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The RK-group receives four intra-articular injections via catheter with a total volume of 40 ml (380 mg ropivacaine and 60 mg ketorolac) combined with 4 intravenous injections of saline during 24 hours postoperatively
The K-group receives four intra-articular injections via catheter with a total volume of 40 ml saline combined with 4 intravenous injections of ketorolac (total 60 mg) during 24 hours postoperatively
Time frame: 24 hours postoperatively
Cummulative morphine comsumption postoperatively
Time frame: 24 hours postoperatively
Pain intensity measured on the visual analog scale (VAS) at rest and during walking
Time frame: 24 hours postoperatively
Number of episodes of nausea measured on a 3 points rating scale (mild, moderate and severe)
University of Aarhus
Other
Local Infiltration Analgesia in Total Hip Arthroplasty - Efficacy of Multiple Bolus Injections With Ropivacaine and Ketorolac
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial DetailsNCT04343807
Agnosia, Anaesthesia
Karachi, Sindh, Pakistan
View Trial DetailsNCT04943874
Acute Pain, Neurologic Manifestations
Wilmington, Delaware, United States
View Trial DetailsNCT06551922
Arthralgia, Joint Diseases
Lahore, Punjab Province, Pakistan
View Trial Details